Jeffrey Janus, president of International Stem Cell, said: “This partnership will lead to a significant expansion in International Stem Cell’s revenue generation through the manufacture of high quality
The focus of the collaboration is to conduct preclinical toxicology evaluations of two new S aureus antigens as components of the multivalent vaccine, targeting Staphylococcus aureus infections. The
Paul Lisenby, CEO of XTend Medical, said: “This agreement will deliver to AmeriChoice a comprehensive solution that will allow their diabetic patients to be remotely monitored and communicate
The goal of the study is to examine the safety and efficacy of the Biostat disc augmentation system in the treatment of chronic discogenic low back pain resulting
The study is intended to evaluate the safety, tolerability and efficacy of ORMD 0801, Oramed’s oral insulin capsule, on diabetic type 2 patients. It is anticipated that the
In his new role, Dr Luskey will lead the clinical development of Intarcia’s proprietary drug development programs including Omega Duros therapy for hepatitis C and ITCA 650 for
Pursuant to the agreement, CompuMed will provide remote electrocardiogram interpretation systems and services at selected facilities nationwide. Maurizio Vecchione, CEO of CompuMed, said: “We’re delighted to team with
In addition to the Phase IIb zoster study, valomaciclovir will also be studied in a separate Phase II clinical trial as a therapy in managing the most severe
In his position, Dr Shearer will oversee the medical components of Integrated Clinical Trial Services (ICTS)-affiliated clinical trials, which include such duties as protocol review and quality assurance
Together they have developed a brand-new technology called Oncentra GYN, Nucletron’s image-guided adaptive brachytherapy for cervical cancer. Together with the Vienna Ring Applicator, Oncentra GYN provides a unique
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.